<HTML>
<HEAD>
<TITLE>
</TITLE>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<FONT SIZE=3 ><A HREF="#02PHI1417_1">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>
<P ALIGN="CENTER"><FONT SIZE=2>
As filed with the Securities and Exchange Commission on July&nbsp;17, 2002 </FONT></P>

<P ALIGN="RIGHT"><FONT SIZE=2>Registration
No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<HR NOSHADE>
<HR NOSHADE>
<P ALIGN="CENTER"><FONT SIZE=5><B>SECURITIES AND EXCHANGE COMMISSION<BR>  </B></FONT><FONT SIZE=2>Washington, D.C. 20549 </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=5><B>FORM S-8<BR>  </B></FONT><FONT SIZE=4><B>REGISTRATION STATEMENT<BR>
UNDER<BR>
THE SECURITIES ACT OF 1933  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=4><B>VIASYS HEALTHCARE&nbsp;INC.<BR>  </B></FONT><FONT SIZE=2>(Exact name of issuer as specified in its charter) </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="BOTTOM">
<TD WIDTH="49%" ALIGN="CENTER" VALIGN="TOP"><FONT SIZE=2>Delaware</FONT></TD>
<TD WIDTH="3%" VALIGN="TOP"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="49%" ALIGN="CENTER" VALIGN="TOP"><FONT SIZE=2>04-3505871</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="49%" ALIGN="CENTER" VALIGN="TOP"><FONT SIZE=2>(State or other jurisdiction of<BR>
incorporation of organization)</FONT></TD>
<TD WIDTH="3%" VALIGN="TOP"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="49%" ALIGN="CENTER" VALIGN="TOP"><FONT SIZE=2>(I.R.S. Employer Identification No.)</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER"><FONT SIZE=2>227 Washington Street, Suite 200<BR>
Conshohocken, PA 19428<BR>
(Address of principal executive offices) </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>VIASYS
Healthcare&nbsp;Inc. Equity Incentive Plan<BR>
(Full title of the plans) </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>Randy
H. Thurman<BR>
President and Chief Executive Officer<BR>
VIASYS Healthcare&nbsp;Inc.<BR>
227 Washington Street, Suite 200<BR>
Conshohocken, PA 19428<BR>
(Name and address of agent for service) </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>(610)&nbsp;862-0800<BR>
(Telephone number, including area code, of agent for service) </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>Copy
to:<BR>
Stephen A. Jannetta, Esq.<BR>
Morgan, Lewis&nbsp;&amp; Bockius LLP<BR>
1701 Market Street<BR>
Philadelphia, PA 19103<BR>
(215)&nbsp;963-5000 </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B>CALCULATION OF REGISTRATION FEE  </B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD COLSPAN=9 VALIGN="BOTTOM"><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="32%" ALIGN="CENTER" VALIGN="BOTTOM"><FONT SIZE=1><B>Title of securities to be registered</B></FONT></TD>
<TD WIDTH="1%" VALIGN="BOTTOM"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER" VALIGN="BOTTOM"><FONT SIZE=1><B>Number of shares to be registered</B></FONT></TD>
<TD WIDTH="1%" VALIGN="BOTTOM"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER" VALIGN="BOTTOM"><FONT SIZE=1><B>Proposed maximum offering price per share</B></FONT></TD>
<TD WIDTH="1%" VALIGN="BOTTOM"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="19%" ALIGN="CENTER" VALIGN="BOTTOM"><FONT SIZE=1><B>Proposed maximum aggregate offering price</B></FONT></TD>
<TD WIDTH="1%" VALIGN="BOTTOM"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER" VALIGN="BOTTOM"><FONT SIZE=1><B>Amount of registration fee</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=9 VALIGN="BOTTOM"><HR NOSHADE></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="32%"><FONT SIZE=2>Common Stock, $0.01 per share</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER"><FONT SIZE=2>2,000,000</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER"><FONT SIZE=2>$15.40(2)</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="19%" ALIGN="CENTER"><FONT SIZE=2>$30,800,000(2)</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER"><FONT SIZE=2>$2,833.60(2)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=9 VALIGN="BOTTOM"><HR NOSHADE></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD><FONT SIZE=2>Estimated
pursuant to Paragraphs (c)&nbsp;and (h)&nbsp;of Rule&nbsp;457 under the Securities Act of 1933 solely for the purpose of calculating the registration fee, based upon
the average of the high and low sales prices of shares of the Company's Common Stock on July&nbsp;10, 2002, as reported on The New York Stock Exchange. </FONT></DD></DL>
<BR>
<HR NOSHADE>
<HR NOSHADE>
<HR NOSHADE>
<!-- ZEQ.=1,SEQ=1,EFW="2084692",CP="VIASYS HEALTHCARE INC.",DN="1",CHK=644251,FOLIO='blank',FILE='DISK006:[02PHI7.02PHI1417]BA1417A.;5',USER='JDEMPST',CD='17-JUL-2002;11:38' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="page_bc1417_1_2"> </A> </FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="bc1417_explanatory_note"> </A>
<A NAME="toc_bc1417_1"> </A>
<BR></FONT><FONT SIZE=2><B>EXPLANATORY NOTE    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;VIASYS Healthcare&nbsp;Inc. (the "Company") files this Registration Statement with respect to 2,000,000 shares of its Common Stock that may be offered or sold
pursuant to the Company's Equity Incentive Plan. The Company files this Registration Statement pursuant to Instruction E of Form&nbsp;S-8 and incorporates by reference the contents of
the Registration Statement previously filed by the Company on Form&nbsp;S-8 (File No.&nbsp;333-73152) on November&nbsp;9, 2001. The current registration of 2,000,000
shares of the Company's Common Stock will increase the number of shares registered for issuance under the Equity Incentive Plan to 6,680,000 shares. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="bc1417_part_ii_information_req__bc102465"> </A>
<A NAME="toc_bc1417_2"> </A>
<BR></FONT><FONT SIZE=2><B>PART II<BR>  INFORMATION REQUIRED IN THE REGISTRATION STATEMENT    <BR>  </B></FONT></P>

<P><FONT SIZE=2><A
NAME="bc1417_item_3._incorporation_of_documents_by_reference."> </A>
<A NAME="toc_bc1417_3"> </A></FONT> <FONT SIZE=2><B>Item 3. Incorporation of Documents by Reference.    <BR>  </B></FONT></P>

<P><FONT SIZE=2>The
following documents, as filed by us with the Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended (the "Exchange Act"), are incorporated in this
registration statement by reference: </FONT></P>

<UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(a)</FONT></DT><DD><FONT SIZE=2>Our
Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;29, 2001.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(b)</FONT></DT><DD><FONT SIZE=2>Our
Quarterly Report on Form&nbsp;10-Q for the quarter ended March&nbsp;30, 2002.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(c)</FONT></DT><DD><FONT SIZE=2>Our
Current Report on Form&nbsp;8-K dated May&nbsp;9, 2002.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(d)</FONT></DT><DD><FONT SIZE=2>Our
Current Report on Form&nbsp;8-K dated May&nbsp;23, 2002, as amended.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(e)</FONT></DT><DD><FONT SIZE=2>Our
Current Report on Form&nbsp;8-K dated June&nbsp;4, 2002.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(f)</FONT></DT><DD><FONT SIZE=2>Our
Current Report on Form&nbsp;8-K dated July&nbsp;1, 2002.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(g)</FONT></DT><DD><FONT SIZE=2>The
description of our common stock, set forth in the our registration statement on Form&nbsp;10, as amended. </FONT></DD></DL>
</UL>

<P><FONT SIZE=2>All
documents that we file pursuant to Section&nbsp;13(a), 13(c), 14 and 15(d) of the Exchange Act after the date of this registration statement and prior to the filing of a
post-effective amendment to this registration statement that indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, will be
deemed to be incorporated by reference in this registration statement and to be a part hereof from the date of filing of such documents. Any statement contained in a document incorporated by reference
herein will be deemed to be modified or superseded for purposes hereof to the extent that a statement contained herein (or in any other subsequently filed document that also is incorporated by
reference herein) modifies or supersedes such statement. Any statement so modified or superseded will not be deemed to constitute a part hereof except as so modified or superseded. </FONT></P>

<P><FONT SIZE=2>You
may request a copy of these filings, at no cost, by contacting: Martin P. Galvan, Chief Financial Officer, VIASYS Healthcare&nbsp;Inc., 227 Washington Street, Suite 200, Conshohocken, PA 19428
(telephone number&#151;(610)&nbsp;862-0800). </FONT></P>

<P><FONT SIZE=2>On
May&nbsp;16, 2002, we announced that we had appointed Ernst&nbsp;&amp; Young LLP to replace Arthur Andersen LLP ("Andersen") as our independent public accountants. Our consolidated balance sheets
as of December&nbsp;29, 2001 and December&nbsp;30, 2000, and the related consolidated statements of income, cash flows and comprehensive income and stockholders' investment for each of the three
years in the period ended December&nbsp;29, 2001 incorporated by reference in this registration statement have been audited by Andersen, as stated in their report dated February&nbsp;6, 2002,
which is incorporated by reference herein. After reasonable efforts, we have been unable to obtain Andersen's consent to the incorporation by reference into this registration statement of its report
with respect to the financial </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>2</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=1,SEQ=2,EFW="2084692",CP="VIASYS HEALTHCARE INC.",DN="1",CHK=366624,FOLIO='2',FILE='DISK006:[02PHI7.02PHI1417]BC1417A.;8',USER='JDEMPST',CD='17-JUL-2002;11:38' -->
<A NAME="page_bc1417_1_3"> </A>
<BR>

<P><FONT SIZE=2>
statements. Under these circumstances, Rule&nbsp;437a under the Securities Act of 1933 permits us to file this registration statement without a written consent from Andersen. The absence of such
consent may limit recovery by investors on certain claims. In particular, and without limitation, investors may not be able to assert claims against Andersen under Section&nbsp;11 of the Securities
Act. In addition, the ability of
Andersen to satisfy any claims (including claims arising from Andersen's provision of auditing and other services to us) may be limited as a practical matter due to recent events regarding Andersen. </FONT></P>


<P><FONT SIZE=2><A
NAME="bc1417_item_4._description_of_securities."> </A>
<A NAME="toc_bc1417_4"> </A>
<BR></FONT><FONT SIZE=2><B>Item 4. Description of Securities.    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable. </FONT></P>

<P><FONT SIZE=2><A
NAME="bc1417_item_5._interests_of_named_experts_and_counsel."> </A>
<A NAME="toc_bc1417_5"> </A>
<BR></FONT><FONT SIZE=2><B>Item 5. Interests of Named Experts and Counsel.    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None. </FONT></P>

<P><FONT SIZE=2><A
NAME="bc1417_item_6._indemnification_of_directors_and_officers."> </A>
<A NAME="toc_bc1417_6"> </A>
<BR></FONT><FONT SIZE=2><B>Item 6. Indemnification of Directors and Officers.    <BR>  </B></FONT></P>

<P><FONT SIZE=2>Section&nbsp;102(b)(7)
of the Delaware General Corporation Law (the "DGCL") permits a corporation, in its certificate of incorporation, to limit or eliminate, subject to certain
statutory limitations, the liability of directors to the corporation or its stockholders for monetary damages for breaches of fiduciary duty, except for liability (a)&nbsp;for any breach of the
director's duty of loyalty to the corporation or its stockholders, (b)&nbsp;for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law,
(c)&nbsp;for any willful or negligent payment of an unlawful dividend, stock purchase or redemption, or (d)&nbsp;for any transaction from which the director derived an improper personal benefit.
Article Seventh of our Amended and Restated Certificate of Incorporation provides that the personal liability of our directors is eliminated to the fullest extent permitted by Section&nbsp;102(b)(7)
of the DGCL. </FONT></P>

<P><FONT SIZE=2>Under
Section&nbsp;145 of the DGCL, a corporation has the power to indemnify directors and officers under certain prescribed circumstances and subject to certain limitations against certain costs
and expenses, including attorney's fees actually and reasonably incurred in connection with any action, suit or proceeding, whether civil, criminal, administrative or investigative, to which any of
them is a party by reason of being a director or officer of the corporation if it is determined that the director or officer acted in accordance with the applicable standard of conduct set forth in
such statutory provision. Article Eighth of our Amended and Restated Certificate of Incorporation provides that we will indemnify any person who was or is a party or is threatened to be made a party
to any threatened, pending or completed action, suit or proceeding by reasons of the fact that he or she is or was, or has agreed to become, our director or officer and, if designated by our Board of
Directors as an authorized representative, our employee or agent, against certain liabilities, costs and expenses. Article Eighth further permits us to purchase and maintain insurance on behalf of any
person who is or was our
director, officer, employee or agent, or is or was serving at our request as a director, officer, employee or agent of another entity, against any liability asserted against such person and incurred
by such person in any such capacity or arising out of his status as such, whether or not we would have the power to indemnify such person against such liability under the DGCL. </FONT></P>

<P><FONT SIZE=2>We
have purchased directors and officers liability insurance. </FONT></P>

<P><FONT SIZE=2><A
NAME="bc1417_item_7._exemption_from_registration_claimed."> </A>
<A NAME="toc_bc1417_7"> </A>
<BR></FONT><FONT SIZE=2><B>Item 7. Exemption from Registration Claimed.    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>3</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=2,SEQ=3,EFW="2084692",CP="VIASYS HEALTHCARE INC.",DN="1",CHK=351475,FOLIO='3',FILE='DISK006:[02PHI7.02PHI1417]BC1417A.;8',USER='JDEMPST',CD='17-JUL-2002;11:38' -->
<A NAME="page_bc1417_1_4"> </A>
<BR>

<P><FONT SIZE=2><A
NAME="bc1417_item_8._exhibits."> </A>
<A NAME="toc_bc1417_8"> </A>
<BR></FONT><FONT SIZE=2><B>Item 8. Exhibits.    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following is a list of exhibits filed as part of this Registration Statement. </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="BOTTOM">
<TH WIDTH="10%" ALIGN="CENTER"><FONT SIZE=1><B>Exhibit Number</B></FONT><HR NOSHADE></TH>
<TH WIDTH="3%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="88%" ALIGN="CENTER"><FONT SIZE=1><B>Description</B></FONT><HR NOSHADE></TH>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="10%" ALIGN="CENTER"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="88%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=2>&nbsp;&nbsp;5.1</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="88%"><FONT SIZE=2>Opinion of Morgan, Lewis &amp; Bockius LLP.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="10%" ALIGN="CENTER"><FONT SIZE=2>23.2</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="88%"><FONT SIZE=2>Consent of Morgan, Lewis &amp; Bockius LLP (contained in the opinion of counsel filed as Exhibit 5.1).</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->


<P><FONT SIZE=2><A
NAME="bc1417_item_9._undertakings."> </A>
<A NAME="toc_bc1417_9"> </A>
<BR></FONT><FONT SIZE=2><B>Item 9. Undertakings.    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)
The undersigned registrant hereby undertakes: </FONT></P>

<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </FONT></P>

<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)
To include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act of 1933; </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)
To reflect in the prospectus any facts or events which, individually or together, represent a fundamental change in the information in the registration statement. Notwithstanding
the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or
high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule&nbsp;424(b) if, in the aggregate, the changes in volume and
price represent no more than a 20&nbsp;percent change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in
the registration statement; </FONT></P>

</UL>
</UL>

<P><FONT SIZE=2><I>provided, however,</I></FONT><FONT SIZE=2> that paragraphs (a)(1)(i)&nbsp;and (a)(1)(ii)&nbsp;do not apply if the information required to be included in a
post-effective amendment by those paragraphs is contained in periodic reports filed by the registrant pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the Exchange Act that are
incorporated by reference in this Registration Statement. </FONT></P>

<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)
That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial </FONT><FONT SIZE=2><I>bona fide</I></FONT><FONT SIZE=2> offering
thereof. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)
To remove from registration by means of a post-effective amendment any of the securities being registered that remain unsold at the termination of the offering. </FONT></P>

<P><FONT SIZE=2>(b)
The undersigned registrant hereby undertakes that, for the purpose of determining any liability under the Securities Act of 1933, each filing of the Company's annual report pursuant to
Section&nbsp;13(a) or Section&nbsp;15(d) of the Securities Exchange Act of 1934 that is incorporated by reference in this registration statement shall be deemed to be a new registration statement
relating to the securities
offered therein and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </FONT></P>

<P><FONT SIZE=2>(c)
Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing
provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and </FONT></P>

</UL>
<P ALIGN="CENTER"><FONT SIZE=2>4</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=3,SEQ=4,EFW="2084692",CP="VIASYS HEALTHCARE INC.",DN="1",CHK=262177,FOLIO='4',FILE='DISK006:[02PHI7.02PHI1417]BC1417A.;8',USER='JDEMPST',CD='17-JUL-2002;11:38' -->
<A NAME="page_bc1417_1_5"> </A>
<UL>
<BR>

<P><FONT SIZE=2>
Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities
(other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is
asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by
controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final
adjudication of such issue. </FONT></P>

</UL>
<P ALIGN="CENTER"><FONT SIZE=2>5</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=4,SEQ=5,EFW="2084692",CP="VIASYS HEALTHCARE INC.",DN="1",CHK=489748,FOLIO='5',FILE='DISK006:[02PHI7.02PHI1417]BC1417A.;8',USER='JDEMPST',CD='17-JUL-2002;11:38' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="page_be1417_1_6"> </A> </FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="be1417_signatures"> </A>
<A NAME="toc_be1417_1"> </A>
<BR></FONT><FONT SIZE=2><B>SIGNATURES    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant has reasonable grounds to believe that it meets all of the requirements for
filing on Form&nbsp;S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Conshohocken, Pennsylvania, on this
17th day of July, 2002. </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="78%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="47%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2>VIASYS HEALTHCARE INC.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="47%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="45%" ALIGN="CENTER"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>MARTIN P. GALVAN</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE><FONT SIZE=2> Martin P. Galvan<BR>
Vice President, Chief Financial Officer</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER"><FONT SIZE=2>6</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=1,SEQ=6,EFW="2084692",CP="VIASYS HEALTHCARE INC.",DN="1",CHK=300657,FOLIO='6',FILE='DISK006:[02PHI7.02PHI1417]BE1417A.;2',USER='MBARTAS',CD='17-JUL-2002;11:15' -->
<A NAME="page_be1417_1_7"> </A>
<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="be1417_viasys_healthcare_inc._exhibit_index"> </A>
<A NAME="toc_be1417_2"> </A>
<BR></FONT><FONT SIZE=2><B>VIASYS HEALTHCARE&nbsp;INC.<BR>  EXHIBIT INDEX    <BR>  </B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="79%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="BOTTOM">
<TH WIDTH="10%" ALIGN="CENTER"><FONT SIZE=1><B>Exhibit Number</B></FONT><HR NOSHADE></TH>
<TH WIDTH="3%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="88%" ALIGN="CENTER"><FONT SIZE=1><B>Description</B></FONT><HR NOSHADE></TH>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="10%"><FONT SIZE=2><BR>
&nbsp;&nbsp;5.1</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="88%"><FONT SIZE=2><BR>
Opinion of Morgan, Lewis &amp; Bockius LLP.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="10%"><FONT SIZE=2><BR>
23.2</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="88%"><FONT SIZE=2><BR>
Consent of Morgan, Lewis &amp; Bockius LLP (contained in the opinion of counsel filed as Exhibit 5.1).</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER"><FONT SIZE=2>7</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=2,SEQ=7,EFW="2084692",CP="VIASYS HEALTHCARE INC.",DN="1",CHK=27992,FOLIO='7',FILE='DISK006:[02PHI7.02PHI1417]BE1417A.;2',USER='MBARTAS',CD='17-JUL-2002;11:15' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<P><br><A NAME="02PHI1417_1">QuickLinks</A><br></P><!-- TOC_BEGIN -->
<FONT SIZE=2><A HREF="#toc_bc1417_1">EXPLANATORY NOTE</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_bc1417_2">PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</A></FONT><BR>
<UL>
<FONT SIZE=2><A HREF="#toc_bc1417_3">Item 3. Incorporation of Documents by Reference.</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_bc1417_4">Item 4. Description of Securities.</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_bc1417_5">Item 5. Interests of Named Experts and Counsel.</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_bc1417_6">Item 6. Indemnification of Directors and Officers.</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_bc1417_7">Item 7. Exemption from Registration Claimed.</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_bc1417_8">Item 8. Exhibits.</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_bc1417_9">Item 9. Undertakings.</A></FONT><BR>
</UL>
<!-- TOC_BEGIN -->
<FONT SIZE=2><A HREF="#toc_be1417_1">SIGNATURES</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_be1417_2">VIASYS HEALTHCARE INC. EXHIBIT INDEX</A></FONT><BR>
<!-- SEQ=,FILE='QUICKLINK',USER=AMCMICH,SEQ=,EFW="2084692",CP="VIASYS HEALTHCARE INC.",DN="1" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "a2084692zs-8.htm", "description": "FORM S-8", "secsgml_size_bytes": 26213}]
{"company-data": {"conformed-name": "VIASYS HEALTHCARE INC", "cik": "0001123361", "assigned-sic": "5047", "irs-number": "043505871", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-96625", "film-number": "02704939"}, "business-address": {"street1": "MILLENIUM III, SUITE 200", "street2": "227 WASHINGTON STREET", "city": "CONSHOHOCKEN", "state": "PA", "zip": "19428", "phone": "610-862-0800"}, "mail-address": {"street1": "MILLENIUM III, SUITE 200", "street2": "227 WASHINGTON STREET", "city": "CONSHOHOCKEN", "state": "PA", "zip": "19428"}, "former-company": {"former-conformed-name": "THERMO BIOMEDICAL INC", "date-changed": "20000906"}}
QuickLinks
-- Click here to rapidly navigate through this document
As filed with the Securities and Exchange Commission on July 17, 2002
Registration
No. 333-
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
VIASYS HEALTHCARE INC.
(Exact name of issuer as specified in its charter)
Delaware
04-3505871
(State or other jurisdiction of
incorporation of organization)
(I.R.S. Employer Identification No.)
227 Washington Street, Suite 200
Conshohocken, PA 19428
(Address of principal executive offices)
VIASYS
Healthcare Inc. Equity Incentive Plan
(Full title of the plans)
Randy
H. Thurman
President and Chief Executive Officer
VIASYS Healthcare Inc.
227 Washington Street, Suite 200
Conshohocken, PA 19428
(Name and address of agent for service)
(610) 862-0800
(Telephone number, including area code, of agent for service)
Copy
to:
Stephen A. Jannetta, Esq.
Morgan, Lewis & Bockius LLP
1701 Market Street
Philadelphia, PA 19103
(215) 963-5000
CALCULATION OF REGISTRATION FEE
Title of securities to be registered
Number of shares to be registered
Proposed maximum offering price per share
Proposed maximum aggregate offering price
Amount of registration fee
Common Stock, $0.01 per share
2,000,000
$15.40(2)
$30,800,000(2)
$2,833.60(2)
(1)
Estimated
pursuant to Paragraphs (c) and (h) of Rule 457 under the Securities Act of 1933 solely for the purpose of calculating the registration fee, based upon
the average of the high and low sales prices of shares of the Company's Common Stock on July 10, 2002, as reported on The New York Stock Exchange.
EXPLANATORY NOTE
VIASYS Healthcare Inc. (the "Company") files this Registration Statement with respect to 2,000,000 shares of its Common Stock that may be offered or sold
pursuant to the Company's Equity Incentive Plan. The Company files this Registration Statement pursuant to Instruction E of Form S-8 and incorporates by reference the contents of
the Registration Statement previously filed by the Company on Form S-8 (File No. 333-73152) on November 9, 2001. The current registration of 2,000,000
shares of the Company's Common Stock will increase the number of shares registered for issuance under the Equity Incentive Plan to 6,680,000 shares.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The
following documents, as filed by us with the Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended (the "Exchange Act"), are incorporated in this
registration statement by reference:
(a)
Our
Annual Report on Form 10-K for the fiscal year ended December 29, 2001.
(b)
Our
Quarterly Report on Form 10-Q for the quarter ended March 30, 2002.
(c)
Our
Current Report on Form 8-K dated May 9, 2002.
(d)
Our
Current Report on Form 8-K dated May 23, 2002, as amended.
(e)
Our
Current Report on Form 8-K dated June 4, 2002.
(f)
Our
Current Report on Form 8-K dated July 1, 2002.
(g)
The
description of our common stock, set forth in the our registration statement on Form 10, as amended.
All
documents that we file pursuant to Section 13(a), 13(c), 14 and 15(d) of the Exchange Act after the date of this registration statement and prior to the filing of a
post-effective amendment to this registration statement that indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, will be
deemed to be incorporated by reference in this registration statement and to be a part hereof from the date of filing of such documents. Any statement contained in a document incorporated by reference
herein will be deemed to be modified or superseded for purposes hereof to the extent that a statement contained herein (or in any other subsequently filed document that also is incorporated by
reference herein) modifies or supersedes such statement. Any statement so modified or superseded will not be deemed to constitute a part hereof except as so modified or superseded.
You
may request a copy of these filings, at no cost, by contacting: Martin P. Galvan, Chief Financial Officer, VIASYS Healthcare Inc., 227 Washington Street, Suite 200, Conshohocken, PA 19428
(telephone number—(610) 862-0800).
On
May 16, 2002, we announced that we had appointed Ernst & Young LLP to replace Arthur Andersen LLP ("Andersen") as our independent public accountants. Our consolidated balance sheets
as of December 29, 2001 and December 30, 2000, and the related consolidated statements of income, cash flows and comprehensive income and stockholders' investment for each of the three
years in the period ended December 29, 2001 incorporated by reference in this registration statement have been audited by Andersen, as stated in their report dated February 6, 2002,
which is incorporated by reference herein. After reasonable efforts, we have been unable to obtain Andersen's consent to the incorporation by reference into this registration statement of its report
with respect to the financial
2
statements. Under these circumstances, Rule 437a under the Securities Act of 1933 permits us to file this registration statement without a written consent from Andersen. The absence of such
consent may limit recovery by investors on certain claims. In particular, and without limitation, investors may not be able to assert claims against Andersen under Section 11 of the Securities
Act. In addition, the ability of
Andersen to satisfy any claims (including claims arising from Andersen's provision of auditing and other services to us) may be limited as a practical matter due to recent events regarding Andersen.
Item 4. Description of Securities.
Not applicable.
Item 5. Interests of Named Experts and Counsel.
None.
Item 6. Indemnification of Directors and Officers.
Section 102(b)(7)
of the Delaware General Corporation Law (the "DGCL") permits a corporation, in its certificate of incorporation, to limit or eliminate, subject to certain
statutory limitations, the liability of directors to the corporation or its stockholders for monetary damages for breaches of fiduciary duty, except for liability (a) for any breach of the
director's duty of loyalty to the corporation or its stockholders, (b) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law,
(c) for any willful or negligent payment of an unlawful dividend, stock purchase or redemption, or (d) for any transaction from which the director derived an improper personal benefit.
Article Seventh of our Amended and Restated Certificate of Incorporation provides that the personal liability of our directors is eliminated to the fullest extent permitted by Section 102(b)(7)
of the DGCL.
Under
Section 145 of the DGCL, a corporation has the power to indemnify directors and officers under certain prescribed circumstances and subject to certain limitations against certain costs
and expenses, including attorney's fees actually and reasonably incurred in connection with any action, suit or proceeding, whether civil, criminal, administrative or investigative, to which any of
them is a party by reason of being a director or officer of the corporation if it is determined that the director or officer acted in accordance with the applicable standard of conduct set forth in
such statutory provision. Article Eighth of our Amended and Restated Certificate of Incorporation provides that we will indemnify any person who was or is a party or is threatened to be made a party
to any threatened, pending or completed action, suit or proceeding by reasons of the fact that he or she is or was, or has agreed to become, our director or officer and, if designated by our Board of
Directors as an authorized representative, our employee or agent, against certain liabilities, costs and expenses. Article Eighth further permits us to purchase and maintain insurance on behalf of any
person who is or was our
director, officer, employee or agent, or is or was serving at our request as a director, officer, employee or agent of another entity, against any liability asserted against such person and incurred
by such person in any such capacity or arising out of his status as such, whether or not we would have the power to indemnify such person against such liability under the DGCL.
We
have purchased directors and officers liability insurance.
Item 7. Exemption from Registration Claimed.
Not applicable.
3
Item 8. Exhibits.
The following is a list of exhibits filed as part of this Registration Statement.
Exhibit Number
Description
5.1
Opinion of Morgan, Lewis & Bockius LLP.
23.2
Consent of Morgan, Lewis & Bockius LLP (contained in the opinion of counsel filed as Exhibit 5.1).
Item 9. Undertakings.
(a)
The undersigned registrant hereby undertakes:
(1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
(i)
To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;
(ii)
To reflect in the prospectus any facts or events which, individually or together, represent a fundamental change in the information in the registration statement. Notwithstanding
the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or
high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and
price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement.
(iii)
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in
the registration statement;
provided, however,
that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a
post-effective amendment by those paragraphs is contained in periodic reports filed by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are
incorporated by reference in this Registration Statement.
(2)
That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
bona fide
offering
thereof.
(3)
To remove from registration by means of a post-effective amendment any of the securities being registered that remain unsold at the termination of the offering.
(b)
The undersigned registrant hereby undertakes that, for the purpose of determining any liability under the Securities Act of 1933, each filing of the Company's annual report pursuant to
Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 that is incorporated by reference in this registration statement shall be deemed to be a new registration statement
relating to the securities
offered therein and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(c)
Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing
provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and
4
Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities
(other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is
asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by
controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final
adjudication of such issue.
5
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant has reasonable grounds to believe that it meets all of the requirements for
filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Conshohocken, Pennsylvania, on this
17th day of July, 2002.
VIASYS HEALTHCARE INC.
By:
/s/
MARTIN P. GALVAN
Martin P. Galvan
Vice President, Chief Financial Officer
6
VIASYS HEALTHCARE INC.
EXHIBIT INDEX
Exhibit Number
Description
5.1
Opinion of Morgan, Lewis & Bockius LLP.
23.2
Consent of Morgan, Lewis & Bockius LLP (contained in the opinion of counsel filed as Exhibit 5.1).
7
QuickLinks
EXPLANATORY NOTE
PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
Item 4. Description of Securities.
Item 5. Interests of Named Experts and Counsel.
Item 6. Indemnification of Directors and Officers.
Item 7. Exemption from Registration Claimed.
Item 8. Exhibits.
Item 9. Undertakings.
SIGNATURES
VIASYS HEALTHCARE INC. EXHIBIT INDEX